reports
Aarti Drugs Limited: 5 directors
Five Directors at Aarti Drugs Limited bought/sold 389,615 shares at between 439.280INR and 446.540INR. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...
- Nitin Agarwal
Aarti Industries' Q2FY20 results (Outperformer) - Broadly-in-line
Q2FY20 results Aarti Industries’s (AIL) revenues declined by 17%yoy to Rs10.76bn (vs est of 2% yoy growth); Notably, Aarti had demerged its HPC segment, hence revenue growth to that extent is not comparable. Impact on revenues due to sharp fall in RM prices was 7% as Aarti passes on the raw material price increase/decrease to its customer. Moreover, temporary shortage of nitric acid (a key raw material) impacted volumes of base chemicals. Speciality chemicals (83% of revenues) declined by 14...
Ford Equity International Rating and Forecast Report
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.